Search Results - "Gambini, Luca"
-
1
Design, Synthesis, and Structural Characterization of Lysine Covalent BH3 Peptides Targeting Mcl‑1
Published in Journal of medicinal chemistry (22-04-2021)“…Modulating disease-relevant protein–protein interactions (PPIs) using pharmacological tools is a critical step toward the design of novel therapeutic…”
Get full text
Journal Article -
2
Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate
Published in Journal of medicinal chemistry (08-03-2018)“…EphA2 overexpression has been associated with metastasis in multiple cancer types, including melanomas and ovarian, prostate, lung, and breast cancers. We have…”
Get full text
Journal Article -
3
Potential Therapeutic Targeting of Coronavirus Spike Glycoprotein Priming
Published in Molecules (Basel, Switzerland) (22-05-2020)“…Processing of certain viral proteins and bacterial toxins by host serine proteases is a frequent and critical step in virulence. The coronavirus spike…”
Get full text
Journal Article -
4
Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates
Published in Molecules (Basel, Switzerland) (17-06-2021)“…We recently reported on a potent synthetic agent, 135H11, that selectively targets the receptor tyrosine kinase, EphA2. While 135H11 possesses a relatively…”
Get full text
Journal Article -
5
NMR Fingerprints of the Drug-like Natural-Product Space Identify Iotrochotazine A: A Chemical Probe to Study Parkinson's Disease
Published in Angewandte Chemie International Edition (10-06-2014)“…The NMR spectrum of a mixture of small molecules is a fingerprint of all of its components. Herein, we present an NMR fingerprint method that takes advantage…”
Get full text
Journal Article -
6
Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
Published in Pharmaceuticals (Basel, Switzerland) (10-05-2020)“…Recently, we reported on potent EphA2 targeting compounds and demonstrated that dimeric versions of such agents can exhibit remarkably increased agonistic…”
Get full text
Journal Article -
7
Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region
Published in PloS one (13-11-2015)“…Malaria is an infectious disease caused by Plasmodium parasites. It results in an annual death-toll of ~ 600,000. Resistance to all medications currently in…”
Get full text
Journal Article -
8
Correction: Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region
Published in PloS one (04-01-2016)Get full text
Journal Article -
9
Targefrin: A Potent Agent Targeting the Ligand Binding Domain of EphA2
Published in Journal of medicinal chemistry (24-11-2022)“…Overexpression of the receptor tyrosine kinase EphA2 is invariably associated with poor prognosis and development of aggressive metastatic cancers. Guided by…”
Get full text
Journal Article -
10
Lysine Covalent Antagonists of Melanoma Inhibitors of Apoptosis Protein
Published in Journal of medicinal chemistry (11-11-2021)“…We have recently reported on Lys-covalent agents that, based on aryl-sulfonyl fluorides, were designed to target binding site Lys 311 in the X-linked inhibitor…”
Get full text
Journal Article -
11
Covalent Inhibitors of Protein–Protein Interactions Targeting Lysine, Tyrosine, or Histidine Residues
Published in Journal of medicinal chemistry (13-06-2019)“…We have recently reported a series of Lys-covalent agents targeting the BIR3 domain of the X-linked inhibitor of apoptosis protein (XIAP) using a…”
Get full text
Journal Article -
12
Aryl-fluorosulfate-based Lysine Covalent Pan-Inhibitors of Apoptosis Protein (IAP) Antagonists with Cellular Efficacy
Published in Journal of medicinal chemistry (24-10-2019)“…We have recently investigated the reactivity of aryl-fluorosulfates as warheads to form covalent adducts with Lys, Tyr, and His residues. However, the rate of…”
Get full text
Journal Article -
13
Design of Potent pan-IAP and Lys-Covalent XIAP Selective Inhibitors Using a Thermodynamics Driven Approach
Published in Journal of medicinal chemistry (26-07-2018)“…Recently we reported that rapid determination of enthalpy of binding can be achieved for a large number of congeneric agents or in combinatorial libraries…”
Get full text
Journal Article -
14
Stability and Cell Permeability of Sulfonyl Fluorides in the Design of Lys‐Covalent Antagonists of Protein‐Protein Interactions
Published in ChemMedChem (18-11-2020)“…Recently we reported on aryl‐fluorosulfates as possible stable and effective electrophiles for the design of lysine covalent, cell permeable antagonists of…”
Get full text
Journal Article -
15
Human resistin protects against endotoxic shock by blocking LPS–TLR4 interaction
Published in Proceedings of the National Academy of Sciences - PNAS (28-11-2017)“…Helminths trigger multiple immunomodulatory pathways that can protect from sepsis. Human resistin (hRetn) is an immune cell-derived protein that is highly…”
Get full text
Journal Article Web Resource -
16
Abstract 3911: Targeting the EphA2-ligand binding domain for the design of innovative cancer therapeutics
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract Eph receptors are the largest family of receptor tyrosine kinases, and are involved in regulating several cellular processes, including cell…”
Get full text
Journal Article -
17
Aryl-fluorosulfate-based Lysine Covalent pan-Inhibitors of Apoptosis Proteins (IAP) Antagonists with Cellular Efficacy
Published in Journal of medicinal chemistry (08-10-2019)“…We have recently investigated the reactivity of aryl-fluorosulfates as warheads to form covalent adducts with Lys, Tyr, and His residues. However, the rate of…”
Get full text
Journal Article -
18
Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell
Published in ACS chemical biology (21-09-2018)“…EphA2 overexpression is invariably associated with poor prognosis and development of aggressive metastatic cancers in pancreatic, prostate, lung, ovarian, and…”
Get full text
Journal Article -
19
Theranostic Nanocages for Imaging and Photothermal Therapy of Prostate Cancer Cells by Active Targeting of Neuropeptide‑Y Receptor
Published in Bioconjugate chemistry (21-12-2016)“…Gold nanocages (AuNCs) have been shown to be a useful tool for harnessing imaging and hyperthermia therapy of cancer, thanks to their unique optical…”
Get full text
Journal Article -
20
N‐locking stabilization of covalent helical peptides: Application to Bfl‐1 antagonists
Published in Chemical biology & drug design (01-04-2020)“…Recently, it was reported that tetrapeptides cyclized via lactam bond between the amino terminus and a glutamic residue in position 4 (termed here N‐lock) can…”
Get full text
Journal Article